Device Technology

Alma today announces the FDA clearance of its Alma Hybrid combination platform, which includes an ablative 10,600 nm (CO2) laser and nonablative 1570 nm laser for skin resurfacing.

The introduction of artificial intelligence into dermatology has been met with mixed emotions from the medical community. In this episode, Ade Adamson, MD, MPP, explains the benefits and detriments of the application, accuracy, and potential racial diagnostic bias.

At the final part of our Road Map to Recovery webinar recap series, sponsored by Aerolase, our expert panelist answered questions about vaccine mandates, social media marketing, cash balance planning, and more.